A newly-launched syringe designed in the UK offers higher stability for sensitive drugs and a gentler injection for sensitive patients.

The InJentle syringe system, designed by Cambridge Consultants for SCHOTT forma vitrum ag, has unique features that improve drug storage and application.

The 'pinch seal' closure ensures that the drug is not in contact with the metal needle or the adhesive of the syringe, protecting sensitive drugs from interacting with these potential contaminants. The syringe can meet the same stability requirements as a storage vial.

The syringe's needle shield protects the needle and minimises the risk of it developing a 'hook'. The sharper 'virgin' needles make the injection less painful for patients. InJentle can be combined with very thin needles (up to 32 gauge) which are siliconised, improving the patient application.

The needle shield also has a robust tamper-evident closure that enables doctors and patients to determine easily whether the syringe is unused. InJentle has the potential to include further anti-counterfeiting features such as RFID tags.

"InJentle is both 'drug friendly' and 'patient friendly'," said Carmen Heiter, Product Manager, Syringes at SCHOTT. "On the one hand, it enables even very sensitive drugs to be stored safely; on the other hand, it offers easy handling and the ability to use particularly thin needles for a gentle application.

"We are delighted with the result of this partnership with Cambridge Consultants, whose experience of developing novel injection technology has been invaluable in getting this product to the manufacture stage so effectively."

Cambridge Consultants develops innovative products, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. SCHOTT is a technology-driven international group that supplies high-tech solutions for healthcare and other uses.

InJentle syringe